Guardian Drug Co. Inc

FDA inspection history in Dayton, New Jersey, 2004 to 2022

1
Form 483
1
Warning letter

Every document, by year

  • Form 483
  • Warning letter

2004: one warning letter; 2022: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2004One warning letter, at Dayton, New Jersey.
  2. 2022One Form 483, at Dayton, New Jersey.

Cited most

Across all Guardian Drug Co. observations on file

The complete Guardian Drug Co. file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2022-02-17483 Form 483$99
2004-09-15Warning letter Warning letter$99

Investigators on these documents

Edmund F. Mrak (1)Ko U. Min (1)

FEI number 2245306 · most recent document Feb 17, 2022

About Guardian Drug Co. Inc

How many FDA Form 483s has Guardian Drug Co. Inc received?

FDA Intel has 1 Form 483 on file for Guardian Drug Co. Inc; the most recent is dated Feb 17, 2022.

When was Guardian Drug Co. Inc last inspected by FDA?

The most recent FDA inspection document on file for Guardian Drug Co. Inc is a Form 483 dated Feb 17, 2022, for the site in Dayton, New Jersey.

What did FDA cite at Guardian Drug Co. Inc?

The regulations cited most in the observations on file for Guardian Drug Co. Inc are 21 CFR 211.192 (Production record review), 2 times; 21 CFR 211.160 (General requirements), 1 time; 21 CFR 211.188 (Batch production and control records), 1 time.

Has Guardian Drug Co. Inc received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Guardian Drug Co. Inc; the most recent is dated Sep 15, 2004.